Cincinnati / Palo Alto / New York / Washington / DC / White Oak / /
Company
Alexion / Novartis / Amgen / Shire Pharmaceuticals / Agency for Healthcare Quality / Services Administration / Bioconnect Systems / Medicaid Services / Watson Pharmaceuticals / Genentech / Dendreon / GlaxoSmithKline / 3rd Ed. Foundation Press / Schulman Associates Institutional / Wyeth / Health Resources / Bristol-Myers Squibb / Johnson & Johnson / Bayer HealthCare Pharmaceuticals Vivus Affymax Astellas Pharma / Antares Pharma / HealthCare Pharmaceuticals Vivus Affymax Astellas Pharma US Inc. / KHI / Private Partnerships / Genzyme / Medtronic / Affymax / /
Continent
America / /
Country
United States / /
Currency
USD / /
Event
Product Issues / /
Facility
National Institute of Diabetes / Duke University / University of North Carolina / University of North Carolina Chapel Hill School / University of Cincinnati School / Critical Path Institute / Chapel Hill / /
IndustryTerm
treatment of prostate cancer / treatment of benign prostatic hyperplasia / tobacco products / open online mechanism / treatment of anemia associated with chronic renal failure / transparent infrastructure / food products / treatment of hormone refractory prostate cancer / treatment of hyperphosphatemia related to kidney dysfunction / treatment of advanced prostate cancer / medical products / asn-online.org/khi/coi.aspx / patient and provider networks / marketed products / food product development / treatment of Fabry disease / biotechnology / treatment of overactive bladder with symptoms / work / biologic license applications / treatment of atypical hemolytic uremic syndrome / treatment of the signs and symptoms / given product / organ systems / food safety / treatment of erectile dysfunction / improved electrocardiogram algorithms / /
office of New Drugs / Health Resources and Services Administration / Medicare / Duke University / Division of Nephrology and Hypertension / Department of Medicine / National Institute of Diabetes and Digestive / American Society of Nephrology To / Coalition against Major Disease / National Center for Advancing Translational Sciences / CenterWatch / Division of Nephrology / KHI Board / office of Medical Policy / National Institute of Health / Health Initiative / University of Cincinnati School of Medicine / University of North Carolina Chapel Hill School of Medicine / American Society of Nephrology Figure / Stanford University School of Medicine / Critical Path Institute / American Society of Nephrology / Agency for Healthcare Quality and Research / Centers for Disease Control and Prevention / CSRC / National Center for Toxicological Research / Center for Devices and Radiologic Health / US Food and Drug Administration / University of North Carolina / Chapel Hill / Food Safety / Center for Drug Evaluation and Research / American Society of Nephrology Table / Center for Biologics Evaluation and Research / KHI Board of Directors / Agency for Healthcare Research and Quality / /
Person
Gore / Proteon Therapeutics / Katlyn Leight / Ronald J. Falk / Van Lente / Tod Ibrahim / Melissa West / Rachel N. Shaffer / Margaret A. Hamburg / /
CJASN ePress. Published on June 6, 2013 as doi: [removed]CJN[removed]Special Feature Fostering Innovation, Advancing Patient Safety: The Kidney Health Initiative